Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

GPHA2 protein levels

near SUPT3H · rs12199167

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−14, with 2 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 47,745 European ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.0449 higher (95% confidence interval 0.033-0.057); p = 8 × 10−15.

How common The T allele had a frequency of about 36% in the people studied.

Where it sits Chromosome 6, band 6p21.1 — between genes, 59.8 kb from SUPT3H.

How common each version is

CT
Korean KRGDB
C 95.9% · T 4.1%
Korean Korea4K
C 95.7% · T 4.3%
Japanese ToMMo
C 97.0% · T 3.0%
Vietnamese
C 92.6% · T 7.4%
World gnomAD
C 70.6% · T 29.4%
World 1000 Genomes
C 78.1% · T 21.9%
World TOPMed
C 71.5% · T 28.5%

By ancestry gnomAD

East Asian
C 96.1% · T 3.9%
European (non-Finnish)
C 65.4% · T 34.6%
African / African American
C 75.9% · T 24.1%
South Asian
C 76.2% · T 23.8%
Admixed American (Latino)
C 73.0% · T 27.0%
Middle Eastern
C 70.2% · T 29.8%
Finnish
C 64.0% · T 36.0%
Ashkenazi Jewish
C 72.7% · T 27.4%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to GPHA2 protein levels. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to GPHA2 protein levels. That is a smaller link than two copies.
T/T Two copies of the version the research linked to GPHA2 protein levels. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

GPHA2 protein levels (rs12199167). MyGeneLog™. https://www.mygenelog.com/variants/rs12199167

← See all variants